$3.583.58 -0.21-0.21 |(-5.54-5.54 %)
52W H: 50.452W L: 3.51Beta: 2.20
About LENZ Therapeutics Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://lenz-tx.com/
Frequently Asked Questions
What is the 52-week range for LENZ?
The 52-week high is $50.4 and the 52-week low is $3.51.
What is the P/E ratio for LENZ?
The P/E ratio data is currently unavailable.
What is the dividend yield for LENZ?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -43.72%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -586.74%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.76.
Analyst Recommendation Trends
Wall Street analyst consensus for LENZ over the last few months:
2026-09-01
Buy: 5
S.Buy: 5
Hold: 3
Sell: 0
2026-08-01
Buy: 5
S.Buy: 6
Hold: 2
Sell: 0
2026-07-01
Buy: 5
S.Buy: 6
Hold: 2
Sell: 0
2026-06-01
Buy: 5
S.Buy: 6
Hold: 2
Sell: 0
Latest LENZ News
LENZ Therapeutics: Below Cash For A Reason
LENZ Therapeutics, Inc. trades below cash, but weak demand, high burn, and single-asset risk threaten its runway. Read the latest analysis on LENZ stock here.
SeekingAlpha9/25/2026
LENZ Therapeutics: Still Speculative But Priced For Disasters
LENZ Therapeutics: Strong Buy with $21.3 fair value (~266% upside). Vizz peak sales modeled at $375M amid risks & competition.
SeekingAlpha9/4/2026
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-06-15 | Guerard Frederic | +22,100 | - | - |
| 2026-06-15 | Scheiner Zachary | +22,100 | - | - |
| 2026-06-15 | George Jeffrey P. | +22,100 | - | - |
| 2026-06-15 | Drapkin Kimberlee C | +22,100 | - | - |
| 2026-06-15 | RA Capital Healthcare Fund LP | +22,100 | - | - |
| 2026-06-15 | Thunen Shelley B | +22,100 | - | - |
| 2026-06-15 | MCCOLLUM JAMES W | +22,100 | - | - |
| 2026-03-27 | George Jeffrey P. | +5,592 | $8.9217 | $49,890 |
| 2026-03-27 | Schimmelpennink Evert B. | +28,089 | $8.9505 | $251,411 |
| 2026-03-27 | Chevallard Daniel R. | +7,500 | $8.57 | $64,275 |
| 2026-01-02 | Odrich Marc | +14,000 | - | - |
| 2026-01-02 | Odrich Marc | +84,200 | - | - |
| 2026-01-02 | Olsson Shawn | +14,000 | - | - |
| 2026-01-02 | Olsson Shawn | +84,200 | - | - |
| 2026-01-02 | Schimmelpennink Evert B. | +358,100 | - | - |
| 2026-01-02 | Chevallard Daniel R. | +14,000 | - | - |
| 2026-01-02 | Chevallard Daniel R. | +84,200 | - | - |
| 2025-11-17 | Olsson Shawn | -10,000 | - | - |
| 2025-11-17 | Olsson Shawn | -5,788 | $26.3669 | $152,612 |
| 2025-11-17 | Olsson Shawn | -4,212 | $25.7385 | $108,411 |
| 2025-11-17 | Olsson Shawn | +10,000 | $2.08 | $20,800 |
| 2025-11-07 | MCCOLLUM JAMES W | +10,500 | $22.7884 | $239,278 |
| 2025-11-07 | Chevallard Daniel R. | +2,178 | $22.7561 | $49,563 |
| 2025-11-07 | Chevallard Daniel R. | +20 | $22.71 | $454 |